![](/img/cover-not-exists.png)
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
Kaufman, Howard L., Andtbacka, Robert H. I., Collichio, Frances A., Wolf, Michael, Zhao, Zhongyun, Shilkrut, Mark, Puzanov, Igor, Ross, MerrickVolume:
5
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/s40425-017-0276-8
Date:
December, 2017
File:
PDF, 549 KB
english, 2017